Development and migration of protective CD8+ T cells into the nervous system following ocular herpes simplex virus-1 infection - PubMed (original) (raw)
Development and migration of protective CD8+ T cells into the nervous system following ocular herpes simplex virus-1 infection
Anna Lang et al. J Immunol. 2005.
Abstract
After infection of epithelial surfaces, HSV-1 elicits a multifaceted antiviral response that controls the virus and limits it to latency in sensory ganglia. That response encompasses the CD8(+) T cells, whose precise role(s) is still being defined; immune surveillance in the ganglia and control of viral spread to the brain were proposed as the key roles. We tracked the kinetics of the CD8(+) T cell response across lymphoid and extralymphoid tissues after ocular infection. HSV-1-specific CD8(+) T cells first appeared in the draining (submandibular) lymph node on day 5 and were detectable in both nondraining lymphoid and extralymphoid tissues starting on day 6. However, although lymphoid organs contained both resting (CD43(low)CFSE(high)) and virus-specific cells at different stages of proliferation and activation, extralymphoid sites (eye, trigeminal ganglion, and brain) contained only activated cells that underwent more than eight proliferations (CD43(high)CFSE(neg)) and promptly secreted IFN-gamma upon contact with viral Ags. Regardless of the state of activation, these cells appeared too late to prevent HSV-1 spread, which was seen in the eye (from day 1), trigeminal ganglia (from day 2), and brain (from day 3) well before the onset of a detectable CD8(+) T cell response. However, CD8(+) T cells were critical in reducing viral replication starting on day 6 and for its abrogation between days 8 and 10; CD8-deficient animals failed to control the virus, exhibited persisting high viral titers in the brain after day 6, and died of viral encephalitis between days 7 and 12. Thus, CD8(+) T cells do not control HSV-1 spread from primary to tertiary tissues, but, rather, attack the virus in infected organs and control its replication in situ.
Similar articles
- Dok-1 and Dok-2 Are Required To Maintain Herpes Simplex Virus 1-Specific CD8+ T Cells in a Murine Model of Ocular Infection.
Lahmidi S, Yousefi M, Dridi S, Duplay P, Pearson A. Lahmidi S, et al. J Virol. 2017 Jul 12;91(15):e02297-16. doi: 10.1128/JVI.02297-16. Print 2017 Aug 1. J Virol. 2017. PMID: 28490594 Free PMC article. - Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells.
Khan AA, Srivastava R, Chentoufi AA, Geertsema R, Thai NT, Dasgupta G, Osorio N, Kalantari M, Nesburn AB, Wechsler SL, BenMohamed L. Khan AA, et al. J Virol. 2015 Jul;89(13):6619-32. doi: 10.1128/JVI.00788-15. J Virol. 2015. PMID: 25878105 Free PMC article. - Human Asymptomatic Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP13/14 (UL47) Preferentially Recall Polyfunctional Effector Memory CD44high CD62Llow CD8+ TEM Cells and Protect Humanized HLA-A*02:01 Transgenic Mice against Ocular Herpesvirus Infection.
Srivastava R, Khan AA, Garg S, Syed SA, Furness JN, Vahed H, Pham T, Yu HT, Nesburn AB, BenMohamed L. Srivastava R, et al. J Virol. 2017 Jan 3;91(2):e01793-16. doi: 10.1128/JVI.01793-16. Print 2017 Jan 15. J Virol. 2017. PMID: 27847359 Free PMC article. - Of mice and not humans: how reliable are animal models for evaluation of herpes CD8(+)-T cell-epitopes-based immunotherapeutic vaccine candidates?
Dasgupta G, BenMohamed L. Dasgupta G, et al. Vaccine. 2011 Aug 11;29(35):5824-36. doi: 10.1016/j.vaccine.2011.06.083. Epub 2011 Jun 28. Vaccine. 2011. PMID: 21718746 Free PMC article. Review. - Role of Herpes Simplex Virus Type 1 (HSV-1) Glycoprotein K (gK) Pathogenic CD8+ T Cells in Exacerbation of Eye Disease.
Jaggi U, Wang S, Tormanen K, Matundan H, Ljubimov AV, Ghiasi H. Jaggi U, et al. Front Immunol. 2018 Dec 7;9:2895. doi: 10.3389/fimmu.2018.02895. eCollection 2018. Front Immunol. 2018. PMID: 30581441 Free PMC article. Review.
Cited by
- Establishment of HSV1 latency in immunodeficient mice facilitates efficient in vivo reactivation.
Ramakrishna C, Ferraioli A, Calle A, Nguyen TK, Openshaw H, Lundberg PS, Lomonte P, Cantin EM. Ramakrishna C, et al. PLoS Pathog. 2015 Mar 11;11(3):e1004730. doi: 10.1371/journal.ppat.1004730. eCollection 2015 Mar. PLoS Pathog. 2015. PMID: 25760441 Free PMC article. - Dok-1 and Dok-2 Are Required To Maintain Herpes Simplex Virus 1-Specific CD8+ T Cells in a Murine Model of Ocular Infection.
Lahmidi S, Yousefi M, Dridi S, Duplay P, Pearson A. Lahmidi S, et al. J Virol. 2017 Jul 12;91(15):e02297-16. doi: 10.1128/JVI.02297-16. Print 2017 Aug 1. J Virol. 2017. PMID: 28490594 Free PMC article. - Are miRNAs critical determinants in herpes simplex virus pathogenesis?
Bhela S, Rouse BT. Bhela S, et al. Microbes Infect. 2018 Oct-Nov;20(9-10):461-465. doi: 10.1016/j.micinf.2017.12.007. Epub 2017 Dec 26. Microbes Infect. 2018. PMID: 29287990 Free PMC article. Review. - Diversity of the CD8+ T cell repertoire elicited against an immunodominant epitope does not depend on the context of infection.
Rudd BD, Venturi V, Smithey MJ, Way SS, Davenport MP, Nikolich-Zugich J. Rudd BD, et al. J Immunol. 2010 Mar 15;184(6):2958-2965. doi: 10.4049/jimmunol.0903493. Epub 2010 Feb 17. J Immunol. 2010. PMID: 20164421 Free PMC article. - Immunosenescence and vaccination.
Pawelec G. Pawelec G. Immun Ageing. 2005 Nov 24;2:16. doi: 10.1186/1742-4933-2-16. Immun Ageing. 2005. PMID: 16307681 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous